Biopharmaceutical industry dynamics are driving the need for supply chains that are robust and provide manufacturers with more process control, transparency and real-time access to detailed information, where and when they need it. This will require a transformation in the relationship between suppliers and drug manufacturers, who want the ability to not only reduce production-related and process-related risks, but also to improve processes and drug product outcomes.
As a leading partner and supplier to the industry, we continue to strengthen and enhance our supply chain capabilities to help you stay ahead. Our Supply Robustness and Control program incorporates:
- Supply Chain Management, including Sales & Operation Planning
- Risk Management, including Business Continuity and Disaster Recovery Planning
- Quality Control, including Supplier Quality and Change Control Management
- And transparency of information, including our industry-leading Emprove® program
This Guide provides some highlights of our program with a focus on single-use, cell culture media and chromatography.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
